Katharina Stenzel - PhD student at the Institute for Pharmaceutical and Medicinal Chemistry at HHU

Katharina Stenzel, doctoral researcher at the Institute for Pharmaceutical and Medicinal Chemistry at HHU.
Photo: Steffen Köhler

Katharina Stenzel is a doctoral candidate at the Institute for Pharmaceutical and Medicinal Chemistry at HHU. Her research focuses on the synthesis of active substances and their use in cancer therapy. In the course of her work she was able to visit several cooperation partners in Scotland, Australia and Korea. Part of her stays abroad where funded by the German Academic Exchange Service (DAAD).

While staying in the labs of her collaboration partners Katharina was able to work for her own project and test her substances. She also got to know new working environments and gained additional experiences relevant for her own research topic by working with her fellow scientists from abroad.
The collaborations have a long lasting tradition in the research group of her supervisor. Working together with several different collaboration partners all over the world is common practice for research group.
Working in Korea was quite different from staying in Australia regarding the daily working environment as well as the daily contact with each other. However,
„One gets a much higher self-perception as a German scientist, which is different to the work and daily routine back home.“

As a member of the Interdisciplinary Graduate and Research Academy (iGRAD), Katharina Stenzel acknowledges many benefits. She got the chance to look out of the box. As a scientist in the life sciences one is quite occupied doing research in the own subject, however, applying the knowledge is much more complex and versatile than one can imagine during the strict lab work as a PhD student. Participating in the qualification program of iGRAD allows to get an insight into future job requirements and prepare for them.

For the future, Katharina wants to stay in research, but does not exclude the possibility for a job in industry. The acquisition of skills in business administration is therefore already on her mind.

Katharina Stenzel has been interviewed by Mareike Schulz in June 2015.

In person

Katharina Stenzel

2012 - Master of Biochemistry at HHU
MSc Topic: "Synthese und biologische Evaluation neuer Hydroxamsäure-basierter Histon-Deacetylase Inhibitoren"

2010 - Bachelor of Science at HHU
BSc Topic: "Charakterisierung eines PvdS-negativen Stammes von Pseudomonas aeruginosa"

PhD thesis:
"Synthese und biologische Evaluierung von Histon-Deacetylase Inhibitoren"

Research group: 
Prof. Dr. Thomas Kurz, Institute for Pharmaceutical and Medicinal Chemistry at HHU

Additional Informationen:

08-10. 2011 Scientific Internship: Institute of Immunology and Infection Research, University of Edinburgh, Scotland
Subject: "Single Nucleotide Polymorphisms" in mit der Immunantwort und Pathologie von Bilharziose (Schistosomiasis) assoziierten Genen 

09-10.2014 Research Stay: Cardiovascular Research Institute of Kyungpook National University, Republic of Korea
Subject: Synthese und Evaluierung von antihypertensiven Histon-Deacetylase Inhibitoren

11.2014-03.2015 Research Stay: Eskitis Institute for Drug Discovery, Griffith University, Queensland, Australia
Subject: Synthese und biologische Evaluierung von Histon-Deacetylase Inhibitoren zur Antimalariatherapie
Doctoral Fellowship of the DAAD

Member of the Interdisciplinary Graduate and Research Academy (iGRAD)


Finn K. Hansen, Subathdrage D. M. Sumanadasa, Katharina Stenzel, et.al. ”Discovery of HDAC Inhibitors with Potent Activity Against Multiple Malaria Parasite Life Cycle Stages“ European Journal of Medicinal Chemistry 82 (2014) 204-213

Responsible for the content: